Kevin M. Slawin, Chief Technology Officer at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 6,000 shares at $20.00 ($120K) on 2015-07-15, disclosed to the SEC on 2015-07-17.
Scheduled sale ($120k) by Chief Technology Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 1,000 | $20K | 16.7% |
| 2 | $20.00 | 1,500 | $30K | 25.0% |
| 3 | $20.00 | 3,500 | $70K | 58.3% |
| Total | $20.00 avg | 6,000 | $120K | 100% |
| Filing → |
| BLCM | SELL | 2016-09-23 | $936K | — | Filing → |
| BLCM | SELL | 2016-09-20 | $92K | — | Filing → |
| BLCM | SELL | 2016-08-17 | $2.0M | — | Filing → |